A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)-Reference-Cited by-同舟云学术

A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)

Published:2020-09 Issue:9 Volume:140 Page:1784-1793.e2
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Gelfand Joel M.^ORCID,Shin Daniel B.^ORCID,Duffin Kristina Callis^ORCID,Armstrong April W.^ORCID,Blauvelt Andrew^ORCID,Tyring Stephen K.^ORCID,Menter Alan^ORCID,Gottlieb Scott^ORCID,Lockshin Benjamin N.^ORCID,Simpson Eric L.^ORCID,Kianifard Farid^ORCID,Sarkar Rajendra Prasad^ORCID,Muscianisi Elisa^ORCID,Steadman Jennifer^ORCID,Ahlman Mark A.^ORCID,Playford Martin P.^ORCID,Joshi Aditya A.^ORCID,Dey Amit K.^ORCID,Werner Thomas J.^ORCID,Alavi Abass^ORCID,Mehta Nehal N.^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference53 articles.

1. Anticytokine immune therapy and atherothrombotic cardiovascular rsk;Ait-Oufella;Arterioscler Thromb Vasc Biol,2019

2. TNF-α antagonist and vascular inflammation in patients with psoriasis vulgaris: a randomized placebo-controlled study;Bissonnette;J Invest Dermatol,2017

3. Effects of the tumor necrosis factor-α antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial;Bissonnette;Circ Cardiovasc Imaging,2013

4. Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial

5. Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept;Bural;Nucl Med Biol,2006

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of reporting and concordance between sources of adverse events in the treatment of moderate-to-severe psoriasis: a cross-sectional study of RCTs from a Cochrane systematic review;Journal of Clinical Epidemiology;2024-09

2. The role of adipokines in the pathogenesis of psoriasis – a focus on resistin, omentin-1 and vaspin;Expert Opinion on Therapeutic Targets;2024-07-02

3. Generalized Pustular Psoriasis and Systemic Organ Dysfunctions;International Journal of Molecular Sciences;2024-06-06

4. The Impact of Interleukin-17 Inhibitors on Major Adverse Cardiovascular Events in Psoriasis or Psoriatic Arthritis Patients Naive to Biologic Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Cureus;2024-05-24

5. Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review;Vascular Health and Risk Management;2024-05